Abbott Laboratories · ABT · Next earnings

Abbott Laboratories reports Wednesday, Oct 21, 2026

ABT reports before market open with consensus EPS at $1.43 and revenue at $12.99B. Last quarter: Abbott Q2 2026 Beats on EPS, Raises Guidance as Device Pipeline Accelerates

Reports Before market open31 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $1.43 Calendar consensus
Consensus revenue $12.99B Calendar consensus
Report date Oct 21, 2026 Wednesday, date estimated
Session Before market open 31 days away

Where ABT left off: FY2026 Q2

Full report

Abbott Q2 2026 Beats on EPS, Raises Guidance as Device Pipeline Accelerates

EPS surprise +2.3% Reported $1.31 vs $1.28
Revenue surprise +0.6% Reported $12.59B vs $12.52B
Stock move +10.7% Event window
Subsequent drift +9.9% Up to 20 sessions

Full-year adjusted EPS guidance raised to $5.45–$5.60. Full-year comparable sales growth guidance reaffirmed at 6.5%–7.5%. This reverses the prior quarter's lowered guidance posture, where management had guided more cautiously amid a weak respiratory season.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Potential deceleration of U.S. procedural volumes linked to payer policy changes.
  • China volume-based pricing pressure on international sales.
  • Uncertainty in timing of CGM reimbursement expansions and FDA approvals, particularly for Libre Duo U.S. launch.
  • Competitive pressure in electrophysiology, structural heart, and CGM markets.

Questions analysts left open

  • U.S. procedure volume outlook and potential impact on med-tech sales.
  • CGM growth sustainability and timing of U.S. dual-key sensor approval.
  • Visibility and timing of Exact Sciences care-gap program ramp-up.
  • Electrophysiology market share versus competitors.
  • Structural heart U.S. performance and timeline for Amulet 360 launch.

Ask FN2 about ABT next report

Transcript, numbers and history already loaded
What should I watch for in ABT's next earnings report?How did ABT guide last quarter, and is consensus above or below that?Give me the bull and bear case going into ABT earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the ABT recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent ABT quarters

All ABT earnings
+10.7%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q2

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.